In Consulting Services

PharmaNet offers a comprehensive range of early- and late-phase consulting services on topics including: international regulatory affairs; scientific and medical affairs; quality; risk management; chemistry, manufacturing and controls; as well as biopharmaceutical investor issues.

Life Sciences Investments

PharmaNet Consulting offers proven expertise for life science investors, including advice from industry leaders in medicine, science, marketing, and international regulation. PharmaNet professionals can assist you by estimating a new therapy’s market potential, evaluating its fit within your portfolio, assessing technical issues, and defining strategies for benchmarking, compliance, submissions, launch, and commercialization.

 

PharmaNet professionals available for consultation on this topic include:

 

Mike Ryan

Executive Director, Strategic Partnering Services

 

Peggy Schrammel

Vice President, Clinical Research, Phase IV Development

 

PharmaNet Development Group, Inc.504 Carnegie Center, Princeton, NJ 08540Tel 609 951 6800Fax 609 514 0390